INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2024) Q3 2024 |
(Jun 30 2024) Q2 2024 |
(Mar 31 2024) Q1 2024 |
(Dec 31 2023) Q4 2023 |
(Sep 30 2023) Q3 2023 |
Total Revenue |
411.63 |
377.16 |
341.01 |
359.57 |
352.74 |
Cost of Goods and Services Sold |
267.12 |
243.79 |
230.79 |
239.17 |
226.30 |
Gross
Profit |
144.51 |
133.38 |
110.22 |
120.39 |
126.43 |
Selling, Administration, Marketing |
47.03 |
47.18 |
44.33 |
43.13 |
41.18 |
Depriciation & Amortization |
59.17 |
55.34 |
54.04 |
54.61 |
47.74 |
Research & development |
- |
- |
- |
- |
- |
Business Combination, Acquisition Related Costs |
5.45 |
7.84 |
5.01 |
15.04 |
- |
Other operatinig exp. /-income |
8.48 |
- |
- |
4.34 |
- |
Litigation Settlement, Expense |
- |
- |
- |
- |
- |
Southbridge Landfill Closure Charge |
- |
- |
- |
-0.28 |
0.07 |
Expense From Acquisition Activities |
- |
- |
- |
-9.80 |
3.26 |
Total operating costs including COS |
387.25 |
354.15 |
334.17 |
346.21 |
318.55 |
Operating income/-loss
|
24.38 |
23.02 |
6.84 |
13.36 |
34.19 |
Other Deductions / - Income |
Interest expense |
- |
- |
15.88 |
15.87 |
15.75 |
Interest income |
-1.38 |
-2.63 |
-2.81 |
-2.92 |
-5.53 |
Net interest expense/-income |
-1.38 |
-2.63 |
13.07 |
12.95 |
10.22 |
Extinguishment of Debt |
- |
- |
- |
-0.01 |
- |
Cost-method Investments, Other than Temporary Impairment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Gain (Loss) on Contract Termination |
- |
- |
- |
- |
- |
Other loss/ -income |
-0.41 |
-0.48 |
-0.35 |
-0.62 |
-0.23 |
Interest Expense Nonoperating |
15.75 |
15.32 |
- |
- |
- |
Total costs & expenses |
401.20 |
366.37 |
346.89 |
358.53 |
328.55 |
Income /-loss before income taxes |
10.42 |
10.80 |
-5.88 |
1.04 |
24.19 |
Income taxes expenses/-benefit |
4.65 |
3.79 |
-1.77 |
2.85 |
6.02 |
Income after income taxes |
5.77 |
7.01 |
-4.12 |
-1.81 |
18.17 |
Net income/-loss
of other equity |
- |
- |
- |
0.00 |
- |
Income/-loss
from cont. Ops. |
5.77 |
7.01 |
-4.12 |
-1.81 |
18.17 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Discontinued Operation Provision For Loss Gain On Disposal And Adjustment Net Of Tax |
- |
- |
- |
- |
- |
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax Attributable To Parent |
- |
- |
- |
- |
- |
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax Attributable To Parent |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
5.77 |
7.01 |
-4.12 |
-1.81 |
18.17 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
5.77 |
7.01 |
-4.12 |
-1.81 |
18.17 |
EBIT |
9.04 |
8.17 |
7.19 |
13.99 |
34.41 |
EBITD |
68.22 |
63.51 |
61.22 |
68.60 |
82.15 |
EBITDA |
68.96 |
64.25 |
61.97 |
69.34 |
82.87 |